Rakovina Therapeutics Inc.
RKV.V
TSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -744.70K | -599.70K | -558.10K | -531.30K | -482.30K |
| Total Depreciation and Amortization | 99.10K | 97.70K | 99.10K | 99.30K | 100.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 29.60K | 42.50K | 39.80K | 55.10K | 32.60K |
| Change in Net Operating Assets | -407.90K | 138.10K | 226.90K | 99.70K | 54.20K |
| Cash from Operations | -1.02M | -321.40K | -192.20K | -277.10K | -294.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | -- | -- | 112.80K |
| Issuance of Common Stock | 300.00K | 1.70M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -34.80K | -46.00K | -- | 0.00 | -112.80K |
| Cash from Financing | 194.40K | 1.21M | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -829.50K | 883.70K | -192.20K | -277.10K | -294.80K |